Pharmaceutical firms spend billions of dollars to develop the next breakthrough drug and to maintain their market shares. We investigate how pharmaceutical firms use mergers and acquisitions to boost their innovation performance which has been found to result in better performance outcomes....

Appraising pharmaceutical products at different time points of their lifecycle open ups the possibility of reversals in estimates of economic value. A product that erstwhile was rated “not cost-effective” could later on become 'cost-effective'. This paper investigates, within a single...